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Online care platforms can support patients with type 2 diabetes (T2DM) in managing their health. However, in the use of eHealth, a
low participation rate is common. The Proactive Interdisciplinary Self-Management (PRISMA) program, aimed at improving
patients’ self-management skills, was expected to encourage patients to manage their disease through the use of an online
platform. Therefore, the objective of the current study was to investigate whether a group education program can improve the
use of an online care platform in patients with T2DM treated by primary care providers in the Netherlands. In a randomized
controlled trial, patients with T2DM received either PRISMA with usual care or usual care only. During a six-month follow-up
period in 2014-2015, usage (number of log-ons and time spent per session) of an online care platform (e-Vita) aimed at
improving T2DM self-management was assessed. A training about the functionalities of e-Vita was offered. The sample
consisted of 203 patients. No differences were found between the intervention and control groups in the number of patients who
attended the platform training (interested patients) (X2ð1Þ = 0:58; p = 0:45), and the number of patients who logged on at least
once (platform users) (X2ð1Þ = 0:46; p = 0:50). In addition, no differences were found between the groups in the type of
users—patients who logged on twice or more (active users) or patients who logged on once (nonactive users) (X2ð1Þ = 0:56;
p = 0:45). The PRISMA program did not change platform usage in patients with T2DM. In addition, only a small proportion
of the patients logged on twice or more. Patients probably need other encouragements to manage their condition using an
online platform.
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1. Introduction
Worldwide, the prevalence of diabetes mellitus is increasing
dramatically. In the Netherlands, 66 per 1,000 persons have
type 2 diabetes mellitus (T2DM), and this rate is expected
to increase to 80 per 1,000 persons by 2025 [1]. Although
patients with T2DM are primarily treated by primary care
providers, this projected growth is expected to exceed the
number of available providers [2]. Already, diabetes care pro-
viders see an increase in patients, which results in a decrease
in face-to-face time available per patient. This has partly been
tackled by a transfer of tasks, previously performed exclu-
sively by general practitioners (GPs), to other medical profes-
sionals including specialized practice nurses (PNs). To deal
with the increasing number of patients with T2DM and the
burden of diabetes on healthcare, increased patient participa-
tion is needed, including more self-management. Self-
management includes the active participation of patients in
their treatment [3] to minimize the impact of chronic disease
on their physical health and functioning and to enable
patients to cope with the psychological effects of the illness
[4]. Patient participation could be enhanced by offering them
the possibility to track their own medical data together with
tailored advice through eHealth [5].
eHealth applications, and more specifically online care
platforms, provide the opportunity for self-management sup-
port and maintaining and/or improving the quality of
chronic disease management by engaging patients in their
own healthcare [6]. In general, online care platforms are
environments in which patients can get an overview of their
health outcomes, communicate with their care provider,
and/or read information regarding their disease. It has been
shown that such platforms are beneficial for people with
T2DM [7]. These platforms have the potential to support
patients in managing their own health and changing their
lifestyle [8].
So far, the effects of online care platforms reported in sys-
tematic reviews vary [9–11]. Health behaviors and health-
related outcomes have been shown to improve through the
use of eHealth [12–15]. Moreover, these platforms were
shown to be specifically beneficial for people with T2DM
[7]. Therefore, platforms aimed at empowering patients can
potentially decrease the workload of diabetes care providers
and improve the (cost-) effectiveness of diabetes treatment
[16, 17]. Nevertheless, implementation problems, nonadher-
ence, and low participation are common [18–23]. A recent
literature review of studies reporting online care platform
use by patients with diabetes (type 1 and 2) revealed that
29% to 46% of them registered for a platform account; of
those registered, 27% to 76% of patients used the platform
at least once [23]. Platform use was associated with the fol-
lowing factors: patient characteristics (e.g., sociodemo-
graphic, clinical characteristics, and health literacy),
technology (e.g., functionality, usability), and provider
engagement. For facilitating the use of self-management sup-
port through a platform, patients first need to develop an
intention for behavioral change, which can only be achieved
if they have sufficient risk awareness, experience a need for
behavioral change, and feel confident in making these
changes [24]. In the Netherlands, an online care platform
called e-Vita has been developed to improve patients’
self-management skills [25].
Group education could be a helpful way for patients to
obtain an intention for behavioral change [26]. A recent
systematic review suggests that group-based diabetes self-
management education is associated with improved clinical
and psychosocial outcomes [27]. The Proactive Interdisci-
plinary Self-Management (PRISMA) program is aimed at
improving self-management skills in patients with T2DM
[26]. PRISMA appeared to improve self-management behav-
ior in terms of dietary behaviors, foot care, action planning,
and medication adherence [24, 28]. In addition, a pilot study
showed that the PRISMA program is promising for decreas-
ing dietary intake in newly diagnosed, overweight patients
with T2DM in secondary care [26]. PRISMA helps patients
to evaluate their own risk factors, to set personal goals, and
to formulate a realistic action plan. Therefore, the PRISMA
program is expected to increase the patients’ motivation to
behavior change and to motivate patients to manage their
condition using an online platform.
The objective of the current study was to investigate
whether a group education program aimed at empowering
and stimulating self-management in patients with T2DM
can improve the use of an online care platform.
2. Material and Methods
2.1. Study Design. The current study is part of the Diabetes
Education and Self-Management to Increase Empowerment
(DESTINE) study described in detail elsewhere [29]. DES-
TINE is a randomized controlled trial that followed enrolled
patients for six months (Figure 1). The patients with T2DM
received either the PRISMA program with usual care or usual
care only. According to the guidelines of the Dutch College of
GPs (NHG-Standard), usual care involves two to four visits
per year with a PN and one annual check-up with a GP. All
patients had access to the online care platform.
In another substudy of DESTINE, the effects of PRISMA
on medication adherence were described [28]. Therefore,
people 18 years old or older who diagnosed with T2DM
and treated in primary care were included. Eight general
practices in the eastern part of the Netherlands participated,
and eligible patients were selected by GPs. Nonstratified
block randomization was used to allocate participants to
one of the two groups [30]. For the current study, we
followed the methods of du Pon et al. [28].
2.2. Description of the Platform. In a previous study, the
online care platform used for this study (e-Vita) showed that
users of the platform had lower glycated hemoglobin
(HbA1c) levels and reported higher quality of life, better
well-being, lower diabetes-related distress, and better
medication adherence than non-users [5]. However, the
usage of this platform has been shown to be minimal in the
past [5, 31]. Only 11% of the patients who were interested
in the use of a care platform logged on at least once [31].
An improved version of the online platform e-Vita was used
in our study. First, platform adjustments were conducted to
2 Journal of Diabetes Research
make the platform more user-friendly. Second, the log-on
procedure was simplified. Third, a function regarding
communication between patients and their PN was added.
Finally, a training was offered to patients, their companions,
and caregivers about the functionalities of e-Vita, as sug-
gested by Roelofsen et al. [5].
The use of e-Vita was offered as part of a larger pro-
gram that aimed to study the effects of an online platform
for various chronic illnesses (T2DM, chronic obstructive
pulmonary disease, and chronic heart failure). The plat-
form (accessible through app.e-vita.nl) not only contains
information about the patient’s health status but also
offers participants more engaging options, such as formu-
lating personal goals, participating in educational modules,
exchanging messages between patient and care provider,
or searching for information in the “library.” The language
of the platform is Dutch. Table 1 shows these items in
more detail.
In both groups, participants (and their spouses) had
the option to use the platform. Therefore, participants
were registered on e-Vita and were invited for a 90-
minute training about this platform. In groups of 5–10,
patients were introduced to e-Vita and received log-on
data. Spouses were also invited due to their important
role in supporting the patient who wish to access and
use the platform [32]. They also became familiarized
with the content by completing several exercises on the
platform (e.g., “enter your weight” or “formulate a
health goal”). After this training, participants were able
to start using the platform immediately. The PNs also
received training about how to use e-Vita to be able
to respond to their patients’ messages, answer questions
about the platform, and follow their patients’ activity
in the educational modules.
2.3. Description of the Intervention. The intervention con-
sisted of two group meetings about T2DM guided by care
providers. The PRISMA program has been described in detail
in du Pon et al. [29]. During PRISMA, patients were encour-
aged to set personal goals and formulate a realistic action
plan. They could enter these personal goals on e-Vita and
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Figure 1: Overview of the complete DESTINE trial of which the current study is part of PRISMA=Proactive Interdisciplinary Self-
Management; RCT= randomized controlled trial. ∗Clinical data includes HbA1c, body mass index (BMI), systolic blood pressure, and
cholesterol levels.
3Journal of Diabetes Research
2.4. Outcomes. The outcome of this study was the change
between groups in the usage of the e-Vita platform (number
of log-ons and time spent per session), as assessed by user log
files.
2.4.1. Usage of the e-Vita Platform. Each action performed
by the users was logged in a file that was saved to the
server and was available for the researcher. Log-in and
log-out times of each session of all platform users were
registered. First, for all platform users, the number of
log-ons, the time spent per session, and the total time
spent on the platform were calculated. Then, patients were
defined according to what type of platform user they were
(Figure 2) [25]. A session included all log-ons to the plat-
form within 30 minutes [33].
2.4.2. Baseline Demographic and Clinical Data. Demographic
baseline data were obtained from questionnaires, including
sex, age, education level, health-related quality of life,
emotional well-being, quality of received care, and eHealth
literacy. Participants of the intervention group received the
paper-based questionnaires immediately after the PRISMA
program, whereas those of the control group received
them by post.
Health-related quality of life was assessed by the EuroQol
Five Dimension (EQ-5D-3L) scale [34]. This questionnaire
consists of two parts: the EQ-5D descriptive system and the
EQ visual analog scale (EQ-VAS). The EQ-5D-3L comprises
five dimensions: mobility, self-care, usual activities, pain/dis-
comfort, and anxiety/depression. Each dimension has three
levels: no problems, some problems, and extreme problems.
The EQ-5D-3L includes a visual analog scale (EQ-VAS) from
which an individual rates their own health today from 0
(worst imaginable health) to 100 (best imaginable health).
Emotional well-being was assessed by the 5-Item World
Health Organization Well-Being Index (WHO-5) scale
[35]. The WHO-5 covers five items: subjective quality of life
based on positive mood (good spirits, relaxation), vitality
(being active, waking up fresh and rested), and general inter-
est (being interested in things). Each of the five items is rated
on a 6-point Likert scale from 0 (not present) to 5 (constantly
present). Higher scores represent higher levels of emotional
well-being. Quality of received care was assessed by the
HowRwe [36]. This questionnaire has four items concerning
promptness, communication, personal relationship, and gen-
eral satisfaction. Each item is scored using four levels ranging
from “excellent” to “poor,” and each level is assigned a score
on a scale from 0 (poor) to 3 (excellent), with higher scores
indicating a better patient experience.
eHealth literacy was assessed by the eHEALS question-
naire, an 8-item scale measuring perceived skills at finding,
evaluating, and applying electronic health information to
health problems [37]. For this study, the four most rele-
vant items were used (α = :90): (1) “I know how to find
helpful health resources on the Internet”; (2) “I know
how to use the Internet to answer my health questions”;
(3) “I know what health resources are available on the
Internet”, and (4) “I feel confident in using information
from the Internet to make health decisions”. The items
were measured with a 5-point Likert scale with response
Table 1: Platform items.
Health status View annual checkups for the last three visits. Every outcome was accompanied by an explanation.
Personal goals Formulate personal goals to reach health-related wishes.
Educational modules
Participate in education presented in text and pictures, followed by a set of simple control
questions. This education was patient specific, based on their health data.
Messages Exchange emails with PN through email program.
“Library”
Look at links to reliable information on T2DM in general, patient associations, and
short videos about patient experiences using the platform.
Interested 
Attended the platform training
Non-interested
Did not attend the platform
training
Non-user
Never logged on after the
training
User
Logged on at least once after
the training
Non-active user
Logged on after the training but
did not meet the criteria for
‘active user’
Active user
Logged on for at least two
sessions of 5 minutes or more
after the training
Figure 2: Flowchart of the process of sorting users into categories by log-on behavior.
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options ranging from “strongly disagree” to “strongly
agree.” Total scores of the eHEALS were summed (possi-
ble range, 4–20), with higher scores representing higher
self-perceived eHealth literacy.
In addition, baseline clinical data (T2DM duration,
HbA1c, body mass index, and systolic blood pressure) were
obtained from the personal health record systems of the
GPs. Only data gathered less than four months before the
intervention were used.
2.5. Sample Size Calculation. To show a difference of at least
20% in active users (15% in the control group versus 35% in
the intervention group) for the primary outcome measure
(usage of the e-Vita platform) with a two-sided risk alpha
of 5% and a power of 80%, 81 individuals per group were
needed using the unpooled Z-test. With an expected
drop-out rate of 20%, we aimed to include 200 patients
in our randomized controlled trial.
2.6. Analysis. Log files were collected for each patient over a
six-month period. An intention to treat (ITT) analysis and
a per protocol (PP) analysis were conducted. The PP analysis
consisted of all patients of the intervention group who
attended at least one session of the PRISMA program.
2.7. Statistical Analysis. All analyses were conducted using
IBM SPSS Statistics version 22. Normally distributed data
were presented as the means and standard deviation, whereas
skewed data were presented as the medians and interquartile
range. Dichotomous/categorical data were presented as num-
bers and percentage of the total. To evaluate differences in
target variables (use of the online platform: number of log-
ons and time spent per session) over time and between arms,
the chi-square test and median difference scores (95% confi-
dence intervals [CI]) were used. A subgroup analysis was
conducted to investigate differences in platform use between
male and female patients, younger (<65 years) and older
patients (>65 years), and patients with a low eHEALS sum
score (12 or less) and patients with a high eHEALS sum score
(13 or more).
2.8. Ethics. This study was reviewed by the Medical Ethics
Committee of Isala, Zwolle, the Netherlands. The committee
decided that formal approval was not necessary (METC no.
14.07104).
3. Results
The inclusion lasted nine months (June 2014 to February
2015). Of 1,476 eligible patients, 203 (13.8%) were included
in the study and signed the informed consent form; 101
patients were randomized to the intervention group and
102 were randomized to the control group. After inclusion,
10 patients (4.9%) withdrew from the study: 6 in the inter-
vention group and 4 in the control group. Patients withdrew
because of illness, immigration, or personal reasons. In the
intervention group, 68 (71.6%) of 95 patients attended at
least one of the two PRISMA meetings. The CONSORT
patient flow chart is presented in Figure 3 [38].
3.1. Patient Characteristics. The patient characteristics are
presented in Table 2. Of the total sample (n = 193), 60.1%
were men. The mean age was 69.9 years (SD, 9.1; range,
35–96). No differences in patient characteristics were found
between groups at baseline.
3.2. Platform Usage. The results of the ITT analyses on the
platform usage are presented in Table 3.
Of the 193 participants in total, 58 (61.1%) patients of the
intervention group and 65 (66.3%) patients of the control
group registered on the platform during the training
(interested patients). At 6 months, 33 (34.7%) patients of
the intervention group and 33 (33.7%) patients of the con-
trol group had logged on to e-Vita once or more (platform
users). Of the intervention group, 12 (12.6%) patients
logged on once (nonactive users); 15 (15.3%) patients of
the control group logged on once. Of the intervention
group, 21 (22.1%) patients logged on twice or more (active
users); 18 (18.4%) patients of the control group logged on
twice or more. No differences were found between the
groups in the number of interested patients (X2ð1Þ = 0:58;
p = 0:45), the number of platform users (X2ð1Þ = 0:46; p =
0:50), or the type of users (X2ð1Þ = 0:56; p = 0:45).
Males more often were interested patient compared to
females (X2ð1Þ = 7:70; p = 0:00). However, no association
was found between sex and being a platform user
(X2ð1Þ = 1:41; p = 0:24) or being an active user of the plat-
form (X2ð1Þ = 0:83; p = 0:36). Also, no association was found
between age and being an interested patient (X2ð1Þ = 0:12;
p = 0:73), a platform user (X2ð1Þ = 0:26; p = 0:61), or active
user of the platform (X2ð1Þ = 0:10; p = 0:92). In addition,
no association was found between self-perceived eHealth
literacy and being an interested patient (X2ð1Þ = 0:71; p =
0:39) or active user of the platform (X2ð1Þ = 0:62; p =
0:43). However, patients with a higher self-perceived
eHealth literacy more often were platform users than
patients with a lower self-perceived eHealth literacy
(X2ð1Þ = 5:01; p = 0:03).
Of all patients, the median number of log-ons was 0
(interquartile range, 0–1) for the intervention group and 0
(interquartile range, 0–1) for the control group. Of the inter-
ested patients, the median number of log-ons was 2 (inter-
quartile range, 1–7) for the intervention group and 2
(interquartile range, 1–5) for the control group with a
median difference score of –0.34 (95% CI, –3.28 to 2.61).
The total time spent on the platform was 56 minutes (inter-
quartile range, 00 : 27–02 : 15) for the intervention group
and 53 minutes (interquartile range, 00 : 27–02 : 14) for the
control group with a median difference score of 0.90 (95%
CI, –50.25 to 52.05).
The results of the PP analysis do not differ from the ITT
results above (data not shown).
4. Discussion
The PRISMA group program, which aimed to improve
T2DM patients’ self-management skills, was expected to
increase patient motivation for behavior change and
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encourage them to manage their disease through the use of
an online platform. However, PRISMA did not result in a
higher platform usage of patients with T2DM over a six-
month period. No differences were found between the groups
regarding the number of log-ons, the length of time spent per
session, and the total time spent on the platform. In addition,
attending the PRISMA intervention did not increase the
chance of becoming a user of the platform or enhanced
patient activity on the platform. Clearly, consideration of
their own personal risk factors and choice of a specific behav-
ior change goal during PRISMA did not encourage patients
(enough) to actually use the platform.
Previous results on the effect of e-Vita usage on clinical
outcomes were promising [25]. However, our study showed
that usage of this platform was minimal. Even offering the
PRISMA program coupled with a training to introduce the
platform did not remove the threshold for patients to use
the platform. Most of the patients who were registered for
platform use and attended the training never logged on.
Going online indeed requires extra effort for which the added
value in view of self-managing a chronic disease using
eHealth may not be automatically apparent for patients
[39]. An explanation could be either a lack of worry about
their future health [40, 41], resulting in an insufficient intrin-
sic motivation, and no intention to change behaviors. In
addition, the absence of disease burden in early-stage
T2DM could lead to a lack of patient motivation to use an
online health platform. Most complications of T2DM arise
on longer term. It would be easier to motivate patients if they
could already see results of their self-management behavior
in the short term. In addition, the mean age of the patient
group was 70 years, and we did not find an association
between age and platform use; however, according to another
study, younger age is associated with platform use [23].
Although the Netherlands is a country with high levels of
general Internet diffusion even among older adults [42], these
new techniques may be not suitable for older generations
who have not mastered the required computer skills [43].
We showed that male patients more often were interested
in platform use compared to female patients, which corre-
sponds to the findings of Roelofsen et al. [5]. Our finding that
high eHealth literate patients used the platform more often
than low eHealth literate patients corresponds to the litera-
ture [44, 45]. The improvement of eHealth literacy in
Withdrawn (n = 4)  Withdrawn (n = 6)
Assessed for eligibility (n = 1,476)
Excluded (n = 1,273)
(i) Did not mee tinclusion criteria (n = 1)
(ii) Declined to participate (n = 165)
(iii) No response to invitation (n = 1,081)   




Randomized (n = 203) 
Enrollment
n = 95 n = 68 n = 98 n = 98
Intervention group (n = 101)
Intervention group (n = 95)
Intention to treat Per protocol Intention to treat Per protocol
Control group (n = 98)
Control group (n = 102)
Figure 3: Flow chart of the participant selection process. Participants in the per protocol analysis attended at least one session of the PRISMA
program.
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patients with T2DM needs attention. A recent literature
review revealed the lack of data accuracy as the most impor-
tant barrier to using eHealth for patients with T2DM [45].
This was often a result of manually reporting or the input
of monitoring data. In our study, we recognized this problem.
Patients probably need other encouragement to manage their
T2DM through a platform, for example by follow-up meet-
ings, counsel sessions, or reminders. Otherwise, a platform
might not be the most appropriate solution to improve self-
management skills in patients with T2DM. The day-to-day
management of T2DM can be complex and challenging
and requires major responsibility of patients. The use of an
online platform would be an extra activity and, as a result,
patients could become overwhelmed. In addition, T2DM
often affects people with a lower socioeconomic status [46],
who could experience other problems considered more
important than their chronic condition.
In our study, 34% of the patients logged on, which was an
improvement from the 11% found in the study by Roelofsen
et al. (2014) on the former version of e-Vita. The trainings
about the functionalities of the platform seemed necessary
to familiarize patients with the platform [45, 47, 48]. This
may also have decreased the threshold for patients to visit
this platform and may have helped patients and PNs to feel
the gains of using it. According to Sieverink (2014), PNs
understand the importance of stimulating self-management
skills of patients with chronic conditions via a platform.
Other possible causes for the increase in platform usage could
be the visual and technical improvements of the platform. In
addition, bended care, where digital health and usual care are
integrated, is likely to lead to increased use of an online pro-
gram for patients with COPD [48]. Patients with diabetes log
on to platforms for various reasons. According to the litera-
ture, frequently used features are viewing laboratory results
[44], sending and reading messages [49], ,and participating
in educational modules [50]; setting personal goals is the least
popular feature [50].
4.1. Strengths and Limitations. To our knowledge, this is the
first study that focuses on the extent to which patients use
an online diabetes care platform after attending a group edu-
cation program. The training offered about the functionali-
ties of e-Vita helped patients to start their first session on
the platform. In addition, communication between health-
care providers and patients, a new function on e-Vita, may
have encouraged the use of the platform. Another strength
of the study was that the participants were randomized over
all general practices. This prevented influences from the gen-
eral practices on the results. In addition, the study has prag-
matic character, which means that it was designed to test
PRISMA in the full spectrum of everyday usual care to max-
imize applicability and generalizability. Therefore, the study
determined whether PRISMA actually increased the platform
usage in real life. In 2017, the platform was renewed,
extended with an app, and used by twenty care groups in
the Netherlands.
Some limitations of this study need to be mentioned as
well. The eight participating general practices diverged by
inclusion rate: of the 1,476 invited patients, most were regis-
tered in three general practices. In addition, despite the
instructions given during the training, the steps to gain access
to the platform were considered complex. These factors
posed a considerable barrier to visiting the platform, espe-
cially for those who were less able to handle computers. In
the beginning of the project, technical problems appeared
on the platform and, as a result, outcomes of patient annual
checkups were not displayed. Furthermore, despite our efforts
to enthuse patients about the PRISMA program, only 12% of
the approached patients participated. Our target group might
not be interested in this type of intervention, which could
explain this low participation rate. In addition, most partici-
pants in our study were moderately or highly educated and
reported a moderate or high eHealth literacy. Lower educated
patients, in whom T2DM is most common [51], may not be
interested in interventions such as PRISMA and e-Vita
because of its complexity. Despite the randomized design,
whether a patient becomes a (active) user of e-Vita could thus
depend on caregiver attitudes toward participation, online
platforms, and eHealth in general (selection bias).
5. Conclusions
The PRISMA program did not result in a higher online
healthcare platform usage in patients with T2DM, and also,
the continuity of use was low. The added value of self-
managing a chronic disease may not be automatically appar-
ent for patients. In addition, platforms may not be suitable
Table 2: Patient characteristics at baseline (n = 193).
n (%)/mean ± SD/median
(25-75 quartiles)
Intervention
group (n = 95)
Control group
(n = 98)
Male 56 (58.9) 60 (61.2)
Age in years 69:7 ± 9:8 70:1 ± 10:1
Education levela
Low 4 (4.2) 8 (8.2)
Moderate 41 (43.2) 45 (45.9)
High 12 (12.6) 11 (11.2)
Unknown 38 (40.0) 34 (34.7)
T2DM duration (years) 6 (4–8) 6 (4–9)
HbA1c (mmol/Mol) 50:7 ± 8:5 54:7 ± 11:7
BMI 28 (26–31) 30 (27–34)
Systolic blood pressure
(mmHg)
139 (131–150) 130 (126–148)
Cholesterol (mmol/L) 4.3 (3.5–5.1) 3.9 (3.4–4.9)
EQ-5D index score 0.9 (0.8–01) 0.9 (0.9–1.0)
WHO-5 index score 76 (61–80) 80 (72–80)
HowRwe sum score 12 (10–12) 12 (9–12)
eHealth literacy 13 (11–16) 13 (11–16)
aLow, no education or primary education; moderate, lower secondary
education, (upper) secondary education, or post-secondary non-tertiary
education (including vocational education); high, tertiary education
(bachelor’s degree or higher). T2DM= type 2 diabetes mellitus;
HbA1c = glycated hemoglobin; BMI = body mass index; EQ-5D = EuroQol
Five Dimension; WHO-5 = 5-Item World Health Organization Well-Being
Index.
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for the older adults with lower eHealth literacy. There is a
need to invest in developing online skills, particularly for
older adults with lower eHealth literacy. Otherwise, these
patients probably need other encouragements to help them
manage T2DM using an online platform. Future research
should explore other sources for patients to develop inten-
tions to behavior change for facilitating the use of self-
management support programs within a platform. Further
development of the platform is ongoing.
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